Paper37460259
Comparing severe COVID-19 outcomes of first and second/third waves: a prospective single-centre cohort study of health-related quality of life and pulmonary outcomes 6 months after infection.
Darlington P and 6 others. BMJ Open, 2023. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Comparing severe COVID-19 outcomes of first and second/third waves: a prospective single-centre cohort study of health-related quality of life and pulmonary outcomes 6 months after infection. Papers, record 37460259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37460259
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparing severe COVID-19 outcomes of first and second/third waves: a prospective single-centre cohort study of health-related quality of life and pulmonary outcomes 6 months after infection.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Quality of Life | Major topic |
| COVID-19 | Major topic |
| Adult | |
| Humans | |
| Prospective Studies | |
| Cohort Studies | |
| Pandemics | |
| Critical Illness | |
| Intensive Care Units | |
| Lung |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35024981 | Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands. | Ann Intensive Care | 2022 | https://conductscience.org/library/papers/35024981 | PubMed |
| 2 | 3811032 | Reference values for lung function tests in men: regression equations with smoking variables. | Ups J Med Sci | 1986 | https://conductscience.org/library/papers/3811032 | PubMed |
| 3 | 34665518 | The role of ventilatory support for long-term outcomes after critical infection with COVID-19: A prospective cohort study. | Clin Respir J | 2022 | https://conductscience.org/library/papers/34665518 | PubMed |
| 4 | 34365975 | One-year follow-up of chest CT findings in patients after SARS-CoV-2 infection. | BMC Med | 2021 | https://conductscience.org/library/papers/34365975 | PubMed |
| 5 | 34474056 | Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults in Sweden. | J Infect | 2022 | https://conductscience.org/library/papers/34474056 | PubMed |
| 6 | 33428867 | 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. | Lancet | 2021 | https://conductscience.org/library/papers/33428867 | PubMed |
| 7 | 35393149 | The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden. | Vaccine | 2022 | https://conductscience.org/library/papers/35393149 | PubMed |
| 8 | 25672277 | ICU survivors show no decline in health-related quality of life after 5 years. | Intensive Care Med | 2015 | https://conductscience.org/library/papers/25672277 | PubMed |
| 9 | 8275167 | The RAND 36-Item Health Survey 1.0. | Health Econ | 1993 | https://conductscience.org/library/papers/8275167 | PubMed |
| 10 | 21470008 | Functional disability 5 years after acute respiratory distress syndrome. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21470008 | PubMed |
| 11 | 35695095 | From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19? | J Enzyme Inhib Med Chem | 2022 | https://conductscience.org/library/papers/35695095 | PubMed |
| 12 | 34751263 | Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study. | Lancet Reg Health Eur | 2021 | https://conductscience.org/library/papers/34751263 | PubMed |
| 13 | 32678530 | Dexamethasone in Hospitalized Patients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/32678530 | PubMed |
| 14 | 35215212 | Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. | Pathogens | 2022 | https://conductscience.org/library/papers/35215212 | PubMed |
| 15 | 34548826 | A Second Wave? What Do People Mean by COVID Waves? - A Working Definition of Epidemic Waves. | Risk Manag Healthc Policy | 2021 | https://conductscience.org/library/papers/34548826 | PubMed |
| 16 | 32017661 | CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). | Radiology | 2020 | https://conductscience.org/library/papers/32017661 | PubMed |
| 17 | 20956146 | Epidemiology of COPD. | Eur Respir Rev | 2009 | https://conductscience.org/library/papers/20956146 | PubMed |
| 18 | 36065136 | How Sweden approached the COVID-19 pandemic: Summary and commentary on the National Commission Inquiry. | Acta Paediatr | 2023 | https://conductscience.org/library/papers/36065136 | PubMed |
| 19 | 33119402 | Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis. | Am J Respir Crit Care Med | 2021 | https://conductscience.org/library/papers/33119402 | PubMed |
| 20 | 29757320 | The Swedish RAND-36 Health Survey - reliability and responsiveness assessed in patient populations using Svensson's method for paired ordinal data. | J Patient Rep Outcomes | 2017 | https://conductscience.org/library/papers/29757320 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41788886 | Outcomes after specialized rehabilitation for patients with critical COVID-19 and prolonged intensive care unit stays. | Eur Clin Respir J | 2026 | https://conductscience.org/library/papers/41788886 | PubMed |
| 40696590 | The assessment of pulmonary impairment and clinical correlations in patients survived from SARS-CoV-2 infection: A 3-month follow-up study. | Medicine (Baltimore) | 2025 | https://conductscience.org/library/papers/40696590 | PubMed |
| 40287680 | Corticosteroids and long-term pulmonary function after critical illness due to COVID-19- a single-center cohort study. | BMC Pulm Med | 2025 | https://conductscience.org/library/papers/40287680 | PubMed |
| 39835287 | Self-reported health, persistent symptoms, and daily activities 2 years after hospitalization for COVID-19. | Front Cell Neurosci | 2024 | https://conductscience.org/library/papers/39835287 | PubMed |
| 38633311 | Residual radiological opacities correlate with disease outcomes in ICU-treated COVID-19. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/38633311 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| GGH | 8836 | PubTator's text mining | https://conductscience.org/library/genes/8836 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37460259
GET https://conductscience.org/api/papers/v1/37460259/references?page=2